002382 蓝帆医疗
已收盘 08-28 15:00:00
资讯
新帖
简况
蓝帆医疗(002382.SZ)发布半年度业绩，归母净利润9567.89万元，同比扭亏为盈
智通财经 · 08-24
蓝帆医疗(002382.SZ)发布半年度业绩，归母净利润9567.89万元，同比扭亏为盈
蓝帆医疗（002382）披露2026年半年度报告，8月24日股价上涨0.17%
证券之星 · 08-24
蓝帆医疗（002382）披露2026年半年度报告，8月24日股价上涨0.17%
蓝帆医疗(002382)8月10日股东户数6.56万户，较上期减少1.98%
证券之星 · 08-24
蓝帆医疗(002382)8月10日股东户数6.56万户，较上期减少1.98%
股市必读：蓝帆医疗新发布《关于子公司向银行申请授信提供担保的进展公告》
证券之星 · 08-24
股市必读：蓝帆医疗新发布《关于子公司向银行申请授信提供担保的进展公告》
蓝帆医疗（002382）披露子公司向银行申请授信提供担保的进展公告，8月20日股价上涨3.98%
证券之星 · 08-20
蓝帆医疗（002382）披露子公司向银行申请授信提供担保的进展公告，8月20日股价上涨3.98%
股市必读：蓝帆医疗新发布《关于转让武汉必凯尔救助用品有限公司100%股权的交易进展暨副总裁辞职的公告》
证券之星 · 08-19
股市必读：蓝帆医疗新发布《关于转让武汉必凯尔救助用品有限公司100%股权的交易进展暨副总裁辞职的公告》
蓝帆医疗（002382）披露转让武汉必凯尔100%股权交易进展暨副总裁辞职公告，8月17日股价上涨0.34%
证券之星 · 08-17
蓝帆医疗（002382）披露转让武汉必凯尔100%股权交易进展暨副总裁辞职公告，8月17日股价上涨0.34%
蓝帆医疗(002382)8月10日股东户数6.56万户，较上期减少1.98%
证券之星 · 08-17
蓝帆医疗(002382)8月10日股东户数6.56万户，较上期减少1.98%
公司问答丨蓝帆医疗：目前公司手套订单充足 整体报价维持行业内相对高位区间
格隆汇 · 08-17
公司问答丨蓝帆医疗：目前公司手套订单充足 整体报价维持行业内相对高位区间
蓝帆医疗：柏盛国际是公司转型升级拓展至心脑血管器械领域的核心战略平台
证券之星 · 07-29
蓝帆医疗：柏盛国际是公司转型升级拓展至心脑血管器械领域的核心战略平台
蓝帆医疗：增持系基于对公司内在价值的认可
证券之星 · 07-29
蓝帆医疗：增持系基于对公司内在价值的认可
蓝帆医疗：两大主业全面盈利与前期战略举措成效集中释放
证券之星 · 07-29
蓝帆医疗：两大主业全面盈利与前期战略举措成效集中释放
蓝帆医疗：本次出售武汉必凯尔100%股权事项无需提交公司股东会审议
证券之星 · 07-29
蓝帆医疗：本次出售武汉必凯尔100%股权事项无需提交公司股东会审议
异动快报：蓝帆医疗（002382）7月15日9点33分触及涨停板
证券之星 · 07-15
异动快报：蓝帆医疗（002382）7月15日9点33分触及涨停板
股市必读：蓝帆医疗（002382）预计2026年1-6月每股收益盈利:0.09元至0.11元
证券之星 · 07-15
股市必读：蓝帆医疗（002382）预计2026年1-6月每股收益盈利:0.09元至0.11元
蓝帆医疗（002382）披露2026年半年度业绩预告，7月14日股价上涨4.43%
证券之星 · 07-14
蓝帆医疗（002382）披露2026年半年度业绩预告，7月14日股价上涨4.43%
股市必读：蓝帆医疗（002382）7月10日董秘有最新回复
证券之星 · 07-13
股市必读：蓝帆医疗（002382）7月10日董秘有最新回复
蓝帆医疗：整体报价维持行业内相对高位区间
证券之星 · 07-10
蓝帆医疗：整体报价维持行业内相对高位区间
蓝帆医疗：本次交易是公司为进一步聚焦核心主业、增厚现金储备、盘活存量资产、缩短管理半径，而基于中长期战略规划做出的主动安排
证券之星 · 07-10
蓝帆医疗：本次交易是公司为进一步聚焦核心主业、增厚现金储备、盘活存量资产、缩短管理半径，而基于中长期战略规划做出的主动安排
蓝帆医疗折价卖“子”回血，*ST明德溢价接盘“求生”，标的盈利下滑让双赢前景成谜
证券之星 · 07-06
蓝帆医疗折价卖“子”回血，*ST明德溢价接盘“求生”，标的盈利下滑让双赢前景成谜
加载更多
公司概况
公司名称：
蓝帆医疗股份有限公司
所属行业：
专用设备制造业
上市日期：
2010-04-02
主营业务：
蓝帆医疗股份有限公司的主营业务是心脑血管业务、健康防护业务及护理业务。公司的主要产品是冠脉支架、冠脉介入球囊、冠脉介入通路、结构性心脏病介入产品、健康防护手套。公司依托持续的技术创新实力与成长潜力，斩获“2025-2026年度医疗器械成长潜力企业”荣誉。
发行价格：
35.00
{"stockData":{"symbol":"002382","market":"SZ","secType":"STK","nameCN":"蓝帆医疗","latestPrice":6.05,"timestamp":1787900592000,"preClose":6.13,"halted":0,"volume":8194000,"delay":0,"changeRate":-0.0131,"floatShares":998000000,"shares":1008000000,"eps":-0.5246,"marketStatus":"已收盘","change":-0.08,"latestTime":"08-28 15:00:00","open":6.08,"high":6.12,"low":6.03,"amount":49632400,"amplitude":0.0147,"askPrice":6.05,"askSize":730,"bidPrice":6.04,"bidSize":1935,"shortable":0,"etf":0,"ttmEps":-0.5246,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788139800000},"marketStatusCode":5,"adr":0,"adjPreClose":6.13,"symbolType":"stock","openAndCloseTimeList":[[1787880600000,1787887800000],[1787893200000,1787900400000]],"highLimit":6.74,"lowLimit":5.52,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1007590726,"isCdr":false,"pbRate":0.87,"roa":"--","roe":"1.34%","epsLYR":-0.76,"committee":0.283098,"marketValue":6096000000,"turnoverRate":0.0082,"status":1,"floatMarketCap":6037000000},"requestUrl":"/m/hq/s/002382","defaultTab":"news","newsList":[{"id":"2661220465","title":"蓝帆医疗(002382.SZ)发布半年度业绩，归母净利润9567.89万元，同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2661220465","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661220465?lang=zh_cn&edition=full","pubTime":"2026-08-24 18:14","pubTimestamp":1787566498,"startTime":"0","endTime":"0","summary":"智通财经APP讯，蓝帆医疗 发布2026年半年度报告，报告期内，公司实现营业收入37.05亿元，同比增长29.67%;归属于上市公司股东净利润9567.89万元，同比扭亏为盈;扣除非经常性损益后归属于上市公司股东的净利润为7972.28万元，同比扭亏为盈;基本每股收益0.1元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484311.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"蓝帆医疗(002382.SZ)发布半年度业绩，归母净利润9567.89万元，同比扭亏为盈","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002382"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661220141","title":"蓝帆医疗（002382）披露2026年半年度报告，8月24日股价上涨0.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661220141","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661220141?lang=zh_cn&edition=full","pubTime":"2026-08-24 18:13","pubTimestamp":1787566393,"startTime":"0","endTime":"0","summary":"截至2026年8月24日收盘，蓝帆医疗报收于5.9元，较前一交易日上涨0.17%，最新总市值为59.45亿元。该股当日开盘5.9元，最高5.98元，最低5.83元，成交额达7418.38万元，换手率为1.26%。近日，蓝帆医疗披露2026年半年度报告。本报告期末总资产为15,467,785,955.21元，较上年度末减少7.72%；归属于上市公司股东的净资产为7,129,943,031.63元，较上年度末减少0.49%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400026025.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002382","BK0114","BK0251","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661722240","title":"蓝帆医疗(002382)8月10日股东户数6.56万户，较上期减少1.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661722240","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661722240?lang=zh_cn&edition=full","pubTime":"2026-08-24 17:32","pubTimestamp":1787563932,"startTime":"0","endTime":"0","summary":"证券之星消息，近日蓝帆医疗披露，截至2026年8月10日公司股东户数为6.56万户，较7月31日减少1326.0户，减幅为1.98%。在医疗器械行业个股中，蓝帆医疗股东户数高于行业平均水平，截至8月10日，医疗器械行业平均股东户数为2.15万户。从股价来看，2026年7月31日至2026年8月10日，蓝帆医疗区间涨幅为4.3%，在此期间股东户数减少1326.0户，减幅为1.98%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400024497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0251","BK0077","002382"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661900245","title":"股市必读：蓝帆医疗新发布《关于子公司向银行申请授信提供担保的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2661900245","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661900245?lang=zh_cn&edition=full","pubTime":"2026-08-24 03:06","pubTimestamp":1787511973,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，蓝帆医疗报收于5.89元，下跌2.0%，换手率1.42%，成交量14.17万手，成交额8345.34万元。当日关注点交易信息汇总：8月21日主力资金净流出595.79万元，占总成交额7.14%。公司公告汇总：子公司吉威医疗获威海银行4,800万元授信，由蓝帆柏盛提供连带责任保证担保，担保余额新增至4,800万元，公司对外担保总额288,885.16万元，占2025年度经审计净资产的40.32%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400001334.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161121","BK0251","BK0077","002382","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660238296","title":"蓝帆医疗（002382）披露子公司向银行申请授信提供担保的进展公告，8月20日股价上涨3.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660238296","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660238296?lang=zh_cn&edition=full","pubTime":"2026-08-20 22:35","pubTimestamp":1787236516,"startTime":"0","endTime":"0","summary":"截至2026年8月20日收盘，蓝帆医疗报收于6.01元，较前一交易日上涨3.98%，最新总市值为60.56亿元。近日，蓝帆医疗披露《关于子公司向银行申请授信提供担保的进展公告》。公告显示，公司子公司山东吉威医疗制品有限公司向威海银行申请4,800万元授信，期限1年；北京蓝帆柏盛医疗科技股份有限公司为其提供连带责任保证担保，担保金额在公司2026年度股东会审议通过的担保额度范围内，无需另行审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000045674.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002382","BK0077","161121","BK0114","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660786499","title":"股市必读：蓝帆医疗新发布《关于转让武汉必凯尔救助用品有限公司100%股权的交易进展暨副总裁辞职的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660786499","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660786499?lang=zh_cn&edition=full","pubTime":"2026-08-19 01:58","pubTimestamp":1787075892,"startTime":"0","endTime":"0","summary":"公司公告汇总关于转让武汉必凯尔救助用品有限公司100%股权的交易进展暨副总裁辞职的公告蓝帆医疗转让武汉必凯尔救助用品有限公司100%股权交易对价为1.90亿元，受让方为明德生物；截至公告日，股权转让款已全额支付，工商变更登记完成，武汉必凯尔不再纳入公司合并报表范围；原副总裁张永臣因交易完成后不再担任公司职务，申请辞去副总裁职位，辞职生效后将专职在武汉必凯尔任职；张永臣持有公司股份45,350股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900001623.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","002382","BK0077","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660343594","title":"蓝帆医疗（002382）披露转让武汉必凯尔100%股权交易进展暨副总裁辞职公告，8月17日股价上涨0.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660343594","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660343594?lang=zh_cn&edition=full","pubTime":"2026-08-17 22:34","pubTimestamp":1786977258,"startTime":"0","endTime":"0","summary":"截至2026年8月17日收盘，蓝帆医疗报收于5.93元，较前一交易日上涨0.34%，最新总市值为59.75亿元。近日，蓝帆医疗发布《关于转让武汉必凯尔救助用品有限公司100%股权的交易进展暨副总裁辞职的公告》。公告显示，公司于2026年6月29日召开董事会，审议通过转让武汉必凯尔救助用品有限公司100%股权的议案，交易对价为1.90亿元，受让方为明德生物。截至公告日，股权转让款已全额支付，工商变更登记完成，武汉必凯尔不再纳入公司合并报表范围。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700035809.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002382","BK0114","BK0251","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660148621","title":"蓝帆医疗(002382)8月10日股东户数6.56万户，较上期减少1.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660148621","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660148621?lang=zh_cn&edition=full","pubTime":"2026-08-17 17:36","pubTimestamp":1786959394,"startTime":"0","endTime":"0","summary":"证券之星消息，近日蓝帆医疗披露，截至2026年8月10日公司股东户数为6.56万户，较7月31日减少1326.0户，减幅为1.98%。在医疗器械行业个股中，蓝帆医疗股东户数高于行业平均水平，截至8月10日，医疗器械行业平均股东户数为2.15万户。从股价来看，2026年7月31日至2026年8月10日，蓝帆医疗区间涨幅为4.3%，在此期间股东户数减少1326.0户，减幅为1.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700023230.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0251","002382","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660100951","title":"公司问答丨蓝帆医疗：目前公司手套订单充足 整体报价维持行业内相对高位区间","url":"https://stock-news.laohu8.com/highlight/detail?id=2660100951","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660100951?lang=zh_cn&edition=full","pubTime":"2026-08-17 15:19","pubTimestamp":1786951186,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0077","002382","BK0251","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655898078","title":"蓝帆医疗：柏盛国际是公司转型升级拓展至心脑血管器械领域的核心战略平台","url":"https://stock-news.laohu8.com/highlight/detail?id=2655898078","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655898078?lang=zh_cn&edition=full","pubTime":"2026-07-29 20:51","pubTimestamp":1785329495,"startTime":"0","endTime":"0","summary":"柏盛国际是公司转型升级拓展至心脑血管器械领域的核心战略平台，该公司搭建了全球化研发、生产、销售完整体系，为蓝帆医疗形成了第二主业增长曲线。截至目前宏达热电运营良好，为公司手套业务今年以来满产全销、扭亏为盈做出了有力贡献，公司未有出售该资产的计划。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900037991.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0251","002382","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655893838","title":"蓝帆医疗：增持系基于对公司内在价值的认可","url":"https://stock-news.laohu8.com/highlight/detail?id=2655893838","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655893838?lang=zh_cn&edition=full","pubTime":"2026-07-29 20:51","pubTimestamp":1785329494,"startTime":"0","endTime":"0","summary":"证券之星消息，蓝帆医疗07月28日在投资者关系平台上答复投资者关心的问题。蓝帆医疗回复：您好，现就您提出的问题逐一回复：1、本次实际控制人及管理层增持均使用个人自有或自筹资金，增持为个人行为，系基于对公司内在价值的认可和未来持续稳定健康发展的坚定信心以及维护股东利益和增强投资者信心而作出增持决定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900037989.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002382","BK0077","BK0114","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655932834","title":"蓝帆医疗：两大主业全面盈利与前期战略举措成效集中释放","url":"https://stock-news.laohu8.com/highlight/detail?id=2655932834","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655932834?lang=zh_cn&edition=full","pubTime":"2026-07-29 08:54","pubTimestamp":1785286449,"startTime":"0","endTime":"0","summary":"证券之星消息，蓝帆医疗07月28日在投资者关系平台上答复投资者关心的问题。后续展望方面，健康防护业务得益于热电联产、产线升级及行业回暖等因素，盈利弹性将持续释放；心脑血管业务随着多款创新产品上市放量、海外代理业务拓展及战略合作项目推进，预计将保持稳健增长。公司将持续推进降本增效，优化总部费用结构，推动两大主业双轮驱动，提升整体盈利能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900007489.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","002382","BK0077","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655834665","title":"蓝帆医疗：本次出售武汉必凯尔100%股权事项无需提交公司股东会审议","url":"https://stock-news.laohu8.com/highlight/detail?id=2655834665","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655834665?lang=zh_cn&edition=full","pubTime":"2026-07-29 08:52","pubTimestamp":1785286328,"startTime":"0","endTime":"0","summary":"证券之星消息，蓝帆医疗(002382)07月28日在投资者关系平台上答复投资者关心的问题。投资者提问：必凯尔的出售股东会何时过会？款收取情况如何？何时讲收到款项？蓝帆医疗回复：您好，本次出售武汉必凯尔100%股权事项无需提交公司股东会审议，已经2026年6月29日召开的公司第六届董事会第四十三次会议审议通过，公司将会同交易对手方依据监管要求有序披露相应进展，您也可同步关注交易对手方的相应公告。感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900007484.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0251","002382","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651292438","title":"异动快报：蓝帆医疗（002382）7月15日9点33分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2651292438","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651292438?lang=zh_cn&edition=full","pubTime":"2026-07-15 09:35","pubTimestamp":1784079338,"startTime":"0","endTime":"0","summary":"证券之星7月15日盘中消息，9点33分蓝帆医疗（002382）触及涨停板。其所属行业医疗器械目前上涨。领涨股为九安医疗。该股为医疗器械，流感，互联网医疗概念热股，当日医疗器械概念上涨0.6%，流感概念上涨0.57%，互联网医疗概念上涨0.56%。7月14日的资金流向数据方面，主力资金净流入1689.03万元，占总成交额20.05%，游资资金净流出440.79万元，占总成交额5.23%，散户资金净流出1248.23万元，占总成交额14.82%。近5日资金流向一览见下表：蓝帆医疗主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500011415.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0251","BK0114","002382"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651488247","title":"股市必读：蓝帆医疗（002382）预计2026年1-6月每股收益盈利:0.09元至0.11元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651488247","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651488247?lang=zh_cn&edition=full","pubTime":"2026-07-15 01:14","pubTimestamp":1784049250,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，蓝帆医疗报收于5.42元，上涨4.43%，换手率1.59%，成交量15.87万手，成交额8422.06万元。公司公告汇总：健康防护事业部预计实现净利润2.5–3.0亿元，心脑血管事业部预计实现净利润约0.9亿元。公司公告汇总2026年半年度业绩预告预计2026年上半年归属于上市公司股东的净利润为9000万元至1.1亿元，同比扭亏为盈；扣除非经常性损益后的净利润为1.7亿元至2.3亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500001722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002382","BK0114","BK0077","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651104317","title":"蓝帆医疗（002382）披露2026年半年度业绩预告，7月14日股价上涨4.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651104317","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651104317?lang=zh_cn&edition=full","pubTime":"2026-07-14 22:17","pubTimestamp":1784038639,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，蓝帆医疗报收于5.42元，较前一交易日上涨4.43%，最新总市值为54.61亿元。该股当日开盘5.18元，最高5.42元，最低5.13元，成交额达8422.06万元，换手率为1.59%。公告显示，公司预计2026年上半年实现归属于上市公司股东的净利润9,000万元至1.1亿元，同比扭亏为盈；扣除非经常性损益后的净利润为1.7亿元至2.3亿元。公司总部费用及利息支出等合计负向影响约1.5亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400049527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","002382","BK0251","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651166348","title":"股市必读：蓝帆医疗（002382）7月10日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2651166348","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651166348?lang=zh_cn&edition=full","pubTime":"2026-07-13 02:10","pubTimestamp":1783879819,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，蓝帆医疗报收于5.24元，上涨2.14%，换手率1.62%，成交量16.21万手，成交额8436.02万元。董秘最新回复投资者： 您好，贵司2020年2.86亿收购的公司，今年1.9亿卖掉，并且还是营收和利润一直在增长的情况下。预计本次交易不存在投资亏损，投资回报符合预期。董秘： 您好，根据相关业务规则，对应2026年6月15日查询口径的股东名册，基准日为2026年6月18日，对应的股东人数为65,053位，感谢您的关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300001089.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","002382","BK0114","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650185606","title":"蓝帆医疗：整体报价维持行业内相对高位区间","url":"https://stock-news.laohu8.com/highlight/detail?id=2650185606","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650185606?lang=zh_cn&edition=full","pubTime":"2026-07-10 16:51","pubTimestamp":1783673466,"startTime":"0","endTime":"0","summary":"证券之星消息，蓝帆医疗(002382)07月10日在投资者关系平台上答复投资者关心的问题。投资者提问：公司的手套有涨价吗？相比年初涨幅是多少？蓝帆医疗回复：您好，目前公司手套产能保持满产满销，整体报价维持行业内相对高位区间，健康防护业务盈利能力较2025年显著改善。感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000029736.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0077","002382","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650185579","title":"蓝帆医疗：本次交易是公司为进一步聚焦核心主业、增厚现金储备、盘活存量资产、缩短管理半径，而基于中长期战略规划做出的主动安排","url":"https://stock-news.laohu8.com/highlight/detail?id=2650185579","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650185579?lang=zh_cn&edition=full","pubTime":"2026-07-10 16:48","pubTimestamp":1783673294,"startTime":"0","endTime":"0","summary":"证券之星消息，蓝帆医疗07月10日在投资者关系平台上答复投资者关心的问题。公司针对该公司所进行的此前收购交易和本次出售交易，两次交易发生节点的宏观市场环境、公司经营策略等因素均有不同。本次交易是公司为进一步聚焦核心主业、增厚现金储备、盘活存量资产、缩短管理半径，而基于中长期战略规划做出的主动安排。预计本次交易不存在投资亏损，投资回报符合预期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000029655.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0251","BK0114","002382"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649764408","title":"蓝帆医疗折价卖“子”回血，*ST明德溢价接盘“求生”，标的盈利下滑让双赢前景成谜","url":"https://stock-news.laohu8.com/highlight/detail?id=2649764408","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649764408?lang=zh_cn&edition=full","pubTime":"2026-07-06 16:14","pubTimestamp":1783325676,"startTime":"0","endTime":"0","summary":"若未达标，蓝帆医疗应在承诺期期满后以现金方式对*ST明德进行补偿；若承诺期满后标的资产期末减值额高于已补偿金额，蓝帆医疗还需另行补偿。受疫情导致防疫物资需求大涨的影响，蓝帆医疗2020年创下归属净利润17.58亿元的历史最好成绩，2021年营收虽创新高，但盈利已现下滑趋势。疫情红利消退业绩“断崖式”暴跌，*ST明德“借道”求生与蓝帆医疗脱手“回血”不同的是，*ST明德出手接盘意在寻求突围。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026070600021317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","002382","BK0239","BK0251","BK0077","002932"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787912782110,"stockEarnings":[{"period":"1week","weight":0.02},{"period":"1month","weight":0.0811},{"period":"3month","weight":-0.0422},{"period":"6month","weight":0.0082},{"period":"1year","weight":-0.0161},{"period":"ytd","weight":0.0946}],"compareEarnings":[{"period":"1week","weight":0.0135},{"period":"1month","weight":0.0376},{"period":"3month","weight":-0.0275},{"period":"6month","weight":-0.0496},{"period":"1year","weight":0.0411},{"period":"ytd","weight":-0.0031}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"蓝帆医疗股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"65646人(较上一季度减少1.98%)","perCapita":"15199股","listingDate":"2010-04-02","address":"山东省淄博市临淄区稷下街道一诺路48号","registeredCapital":"100759万元","survey":" 蓝帆医疗股份有限公司的主营业务是心脑血管业务、健康防护业务及护理业务。公司的主要产品是冠脉支架、冠脉介入球囊、冠脉介入通路、结构性心脏病介入产品、健康防护手套。公司依托持续的技术创新实力与成长潜力，斩获“2025-2026年度医疗器械成长潜力企业”荣誉。","listedPrice":35},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"蓝帆医疗(002382)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供蓝帆医疗(002382)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"蓝帆医疗,002382,蓝帆医疗股票,蓝帆医疗股票老虎,蓝帆医疗股票老虎国际,蓝帆医疗行情,蓝帆医疗股票行情,蓝帆医疗股价,蓝帆医疗股市,蓝帆医疗股票价格,蓝帆医疗股票交易,蓝帆医疗股票购买,蓝帆医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"蓝帆医疗(002382)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供蓝帆医疗(002382)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}